The clinical management of chronic kidney disease leads to an inevitable interplay between recommended therapies and the hazards of impaired renal function. Disturbances in potassium level are a common byproduct of this interaction and can increase the risk of adverse safety outcomes in patients with chronic kidney disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Rose, B. D. & Post, T. W. Clinical Physiology of Acid-Base and Electrolyte Disorders 5th edn (McGraw-Hill, New York, 2001).
Allon, M., Dansby, L. & Shanklin, N. Glucose modulaiton of the disposal of an acute potassium load in patients with end-stage renal disease. Am. J. Med. 94, 475–482 (1993).
Bonilla, S., Goecke, I. A., Bozzo, S., Alvo, M., Michea, L. & Marusic, E. T. Effects of chronic renal failure on Na,K-ATPase alpha 1 and alpha 2 transcription in rat skeletal muscles. J. Clin. Invest. 88, 2137–2141 (1991).
Bunchman, T. E. & Sinaiko, A. R. Renovascular hypertension presenting with hypokalemic metabolic alkalosis. Pediatr. Nephrol. 4, 169–170 (1990).
Fliser, D. Loop diuretics and thiazides—the case for their combination in chronic renal failure. Nephrol. Dial. Transplant. 11, 408–410 (1996).
Weir, M. R. & Rolfe, M. Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors. Clin. J. Am. Soc. Nephrol. 5, 531–548 (2010).
Clayton, J. A., Rodgers, S., Blakey, J., Avery, A. & Hall, I. P. Thiazide diuretic prescription and electrolyte abnormalities in primary care. Br. J. Clin. Pharmacol. 61, 87–95 (2006).
Korgaonkar, S. et al. Serum potassium and outcomes in CKD: insights from the RRI-CKD Cohort Study. Clin. J. Am. Soc. Nephrol. 5, 762–769 (2010).
Einhorn, L. M. et al. The frequency of hyperkalemia and its significance in chronic kidney disease. Arch. Intern. Med. 169, 1156–1162 (2009).
Hoes, A. W. et al. Diuretics, beta-blockers, and the risk for sudden cardiac death in hypertensive patients. Ann. Intern. Med. 123, 481–487 (1995).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Fink, J. The effect of CKD therapies on serum potassium levels. Nat Rev Nephrol 6, 633–634 (2010). https://doi.org/10.1038/nrneph.2010.127
Published:
Issue date:
DOI: https://doi.org/10.1038/nrneph.2010.127
This article is cited by
-
Management of patients with chronic kidney disease
Internal and Emergency Medicine (2011)
